This study investigates the potential role of CCR9 in the recruitment of immune cells known to be crucial during CRC progression (CD8+ T cells versus Tregs), using the Colitis-Associated Colorectal Cancer mice model. Here, CCR9 is linked to colorectal carcinoma.